Clinical Trial Update: Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating INL1 in patients with heart failure and reduced ejection fraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved No Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• INL1

Snippet

Sponsor: Innolife Co., Ltd. | Conditions: Heart Failure, Reduced Ejection Fraction | Phase 2 | Status: UNKNOWN